G. Depergola et al., RELATION BETWEEN SEX-HORMONES AND SERUM-LIPOPROTEIN AND LIPOPROTEIN(A) CONCENTRATIONS IN PREMENOPAUSAL OBESE WOMEN, Arteriosclerosis and thrombosis, 13(5), 1993, pp. 675-679
Lipoprotein(a) (Lp[a]) is generally considered to be a risk factor for
the development of cardiovascular disease, but little is known about
the possible influence of obesity on the circulating levels of this li
poprotein. The present study was undertaken to examine this aspect in
136 menstrually active women by comparing the serum concentrations of
Lp(a) between 72 obese and 64 age-matched nonobese women. Since an adv
erse effect of androgens and a protective effect of estrogens have bee
n described for plasma lipoprotein profiles in obese women, the relati
on between the circulating levels of Lp(a) and those of these other ho
rmones was also investigated in obese patients. In addition. other lip
oproteins, anthropometric parameters (body mass index and waist-to-hip
ratio), and insulin were evaluated. The levels of Lp(a) were not sign
ificantly different (Mann-Whitney U test chi2, 3.59; p=0.0582 [NS]) be
tween obese (rank sum, 5,367) and control (rank sum, 3,949) women; in
addition, the percentage of patients with high Lp(a) levels (cutoff de
fined at 30 mg/dL) did not differ between the two groups (obese women,
30%; control, 21.8%;chi2, 0.90; two-sided p=0.341 [NS]). Moreover, no
correlation was found between Lp(a) and body mass index. Lastly, when
the Lp(a) prevalence odds ratio for obesity was examined by adjusting
the levels of this lipoprotein for age, triglycerides, total choleste
rol, and high density lipoprotein cholesterol, the probability value (
0.88) was far from significant. In obese women, no correlation was fou
nd between the logarithmically transformed Lp(a) concentrations and al
l the other variables evaluated in the study. In conclusion, the prese
nt study shows that the circulating levels of Lp(a) are not influenced
by body weight and cardiovascular risk factors commonly associated wi
th obesity, such as enhanced androgenic activity, hyperinsulinemia, ad
verse lipoprotein profile, and abdominal fat accumulation.